NMUR2 agonists (Takeda Pharmaceutical)

N/A

Report date: 2025/01/26 16:02:22

Base Information

Drug NameNMUR2 agonists (Takeda Pharmaceutical)
Drug Alias Namealkylated peptide (Takeda Pharmaceutical)neuromedin U-8 (NMU-8) analogs (Takeda Pharmaceutical)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeuromedin-U receptor 2 agonists
TargetsNeuromedin-U receptor 2
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A